Neonatal Herpes Simplex Infection

Clinical Microbiology Reviews

Volumn 17, Issue 1, 2004, Pages 1-13

  Kimberlin, David W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; VIDARABINE;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE INFECTION; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; NEWBORN; NEWBORN INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; SURVIVAL; VIRUS CULTURE; VIRUS LATENCY; VIRUS MORPHOLOGY; VIRUS TRANSMISSION;

HERPES SIMPLEX; HUMANS; INFANT, NEWBORN;

DNA VIRUSES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 1642475090     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.1.1-13.2004     Document Type: Review

References (105)

1. American Academy of Pediatrics. 2000. Herpes simplex, p. 309-318. In L. K. Pickering (ed.), 2000 Red Book: report of the Committee on Infectious Diseases, 25th ed. American Academy of Pediatrics, Elk Grove Village, Ill.
2. Anderson, N. E., K. F. Powell, and M. C. Croxson. 1993. A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry 56:520-525.
3. Anonymous. 2000. ACOG practice bulletin. Management of herpes in pregnancy, no. 8, October 1999. Clinical management guidelines for obstetrician-gynecologists. Int. J. Gynaecol. Obstet. 68:165-173.
4. Arvin, A. M., P. A. Hensleigh, C. G. Prober, D. S. Au, L. L. Yasukawa, A. E. Wittek, P. E. Palumbo, S. G. Paryani, and A. S. Yeager. 1986. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med. 315:796-800.
5. Arvin, A. M., A. S. Yeager, F. W. Bruhn, and M. Grossman. 1982. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J. Pediatr. 100:715-721.
6. Ashley, R. L. 2001. Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77:232-237.
7. Ashley, R. L., and M. Eagleton. 1998. Evaluation of a novel point of care test for antibodies to herpes simplex virus type 2. Sex. Transm. Infect. 74:228-229.
8. Ashley, R. L., A. Wald, and M. Eagleton. 2000. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2. Sex. Transm. Dis. 27:266-269.
9. Atkins, J. T. 1999. HSV PCR for CNS infections: pearls and pitfalls. Pediatr. Infect. Dis. J. 18:823-824.
10. Baldwin, S., and R. J. Whitley. 1989. Intrauterine herpes simplex virus infection. Teratology 39:1-10.
11. Barbi, M., S. Binda, V. Primache, A. Tettamanti, C. Negri, and C. Brambilla. 1998. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr. Infect. Dis. J. 17:251-252.
12. Baron, S., M. G. Worthington, J. Williams, and J. W. Gaines. 1976. Post-exposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature 261:505-506.
13. Barton, I. G., G. R. Kinghorn, S. Najem, L. S. Al-Omar, and C. W. Potter. 1982. Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br. J. Vener. Dis. 58:44-47.
14. Batignani, A. 1934. Conjunctivite da virus erpetico in neonato. Boll. Ocul. 13:1217.
15. Bolognese, R. J., S. L. Corson, D. A. Fuccillo, R. Traub, F. Moder, and J. L. Sever. 1976. Herpesvirus hominis type II infections in asymptomatic pregnant women. Obstet. Gynecol. 48:507-510.
16. Boston Interhospital Virus Study Group. 1975. An NIAID-sponsored cooperative antiviral clinical study: failure of high dose 5-iodo-2′ -deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity. N. Engl. J. Med. 292:599-603.
17. Boucher, F. D., L. L. Yasukawa, R. N. Bronzan, P. A. Hensleigh, A. M. Arvin, and C. G. Prober. 1990. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr. Infect. Dis. J. 9:499-504.
18. Braig, S., D. Luton, O. Sibony, C. Edlinger, C. Boissinot, P. Blot, and J. F. Oury. 2001. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur. J. Obstet. Gynecol. Reprod. Biol. 96:55-58.
19. Bravo, F. J., N. Bourne, C. J. Harrison, C. Mani, L. R. Stanberry, M. G. Myers, and D. I. Bernstein. 1996. Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs. J. Infect. Dis. 173:1-6.
20. Brocklehurst, P., G. Kinghorn, O. Carney, K. Helsen, E. Ross, E. Ellis, R. Shen, F. Cowan, and A. Mindel. 1998. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br. J. Obstet. Gynaecol. 105:275-280.
21. Brown, Z. A., J. Benedetti, R. Ashley, S. Burchett, S. Selke, S. Berry, L. A. Vontver, and L. Corey. 1991. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 324:1247-1252.
22. Brown, Z. A., S. Selke, J. Zeh, J. Kopelman, A. Maslow, R. L. Ashley, D. H. Watts, S. Berry, M. Herd, and L. Corey. 1997. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:509-515.
23. Brown, Z. A., L. A. Vontver, J. Benedetti, C. W. Critchlow, C. J. Sells, S. Berry, and L. Corey. 1987. Effects on infants of a first episode of genital herpes during pregnancy. N. Engl. J. Med. 317:1246-1251.
24. Brown, Z. A., A. Wald, R. A. Morrow, S. Selke, J. Zeh, and L. Corey. 2003. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209.
25. Cheong, W. K., T. Thirumoorthy, S. Doraisingham, and A. E. Ling. 1990. Clinical and laboratory study of first episode genital herpes in Singapore. Int. J. STD AIDS 1:195-198.
26. Corey, L., H. G. Adams, Z. A. Brown, and K. K. Holmes. 1983. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann. Intern. Med. 98:958-972.
27. Reference deleted.
28. Corey, L., and A. Wald. 1999. Genital herpes, p. 285-312. In K. K. Holmes, P. F. Sparling, P. A. Mardh, S. M. Lemon, W. E. Stamm, P. Piot, and J. N. Wasserheit (ed.), Sexually transmitted Diseases, 3rd ed. McGraw-Hill, New York, N.Y.
29. Deardourff, S. L., F. A. Deture, D. M. Drylie, Y, Centifano, and H. Kaufman. 1974. Association between herpes hominis type 2 and the male genitourinary tract. J. Urol. 112:126-127.
30. Diamond, C., K. Mohan, A. Hobson, L. Frenkel, and L. Corey. 1999. Viremia in neonatal herpes simplex virus infections. Pediatr. Infect. Dis. J. 18:487-489.
31. Englund, J. A., C. V. Fletcher, and H. H. Balfour, Jr. 1991. Acyclovir therapy in neonates. J. Pediatr. 119:129-135.
32. Fleming, D. T., G. M. McQuillan, R. E. Johnson, A. J. Nahmias, S. O. Aral, F. K. Lee, and M. E. St Louis. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111.
33. Florman, A. L., A. A. Gershon, P. R. Blackett, and A. J. Nahmias. 1973. Intrauterine infection with herpes simplex virus. Resultant congenital malformations. JAMA 225:129-132.
34. Glezen, W. P., G. W. Fernald, and J. A. Lohr. 1975. Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. Am. J. Epidemiol. 101:111-121.
35. Hass, M. 1935. Hepatoadrenal necrosis with intranuclear inclusion bodies: report of a case. Am. J. Pathol. 11:127.
36. Hutto, C., A. Arvin, R. Jacobs, R. Steele, S. Stagno, R. Lyrene, L. Willett, D. Powell, R. Andersen, and J. Werthammer. 1987. Intrauterine herpes simplex virus infections. J. Pediatr. 110:97-101.
37. Johnson, R. E., A. J. Nahmias, L. S. Magder, F. K. Lee, C. A. Brooks, and C. B. Snowden. 1989. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N. Engl. J. Med. 321:7-12.
38. Josey, W. E., A. J. Nahmias, and Z. M. Naib. 1972. The epidemiology of type 2 (genital) herpes simplex virus infection. Obstet. Gynecol. Surv. 27(Suppl):295-302.
39. Josey, W. E., A. J. Nahmias, Z. M. Naib, P. M. Utley, W. J. McKenzie, and M. T. Coleman. 1966. Genital herpes simplex infection in the female. Am. J. Obstet. Gynecol. 96:493-501.
40. Karesh, J. W., S. Kapur, and M. MacDonald. 1983. Herpes simplex virus and congenital malformations. South. Med. J. 76:1561-1563.
41. Kaye, E. M., and E. C. Dooling. 1981. Neonatal herpes simplex meningo-encephalitis associated with fetal monitor scalp electrodes. Neurology 31:1045-1047.
42. Kimberlin, D., D. Powell, W. Gruber, P. Diaz, A. Arvin, M. Kumar, R. Jacobs, R. Van Dyke, S. Burchett, S. J. Soong, A. Lakeman, R. Whitley, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1996. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr. Infect. Dis. J. 15:247-254.
43. Kimberlin, D., S. Weller, R. J. Whitley, W. W. Andrews, J. C. Hauth, F. Lakeman, and G. Miller. 1998. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am. J. Obstet. Gynecol. 179:846-851.
44. Kimberlin, D. W. 2001. Advances in the treatment of neonatal herpes simplex infections. Rev. Med. Virol. 11:157-163.
45. Reference deleted.
46. Kimberlin, D. W., F. D. Lakeman, A. M. Arvin, C. G. Prober, L. Corey, D. A. Powell, S. K. Burchett, R. F. Jacobs, S. E. Starr, R. J. Whitley, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1996. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J. Infect. Dis. 174:1162-1167.
47. Kimberlin, D. W., C. Y. Lin, R. F. Jacobs, D. A. Powell, L. Corey, W. C. Gruber, M. Rathore, J. S. Bradley, P. S. Diaz, M. Kumar, A. M. Arvin, K. Gutierrez, M. Shelton, L. B. Weiner, J. W. Sleasman, T. M. de Sierra, S. Weller, S. J. Soong, J. Kiell, F. D. Lakeman, R. J. Whitley, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2001. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108:230-238.
48. Kimberlin, D. W., C. Y. Lin, R. F. Jacobs, D. A. Powell, L. M. Frenkel, W. C. Gruber, M. Rathore, J. S. Bradley, P. S. Diaz, M. Kumar, A. M. Arvin, K. Gutierrez, M. Shelton, L. B. Weiner, J. W. Sleasman, T. M. de Sierra, S. J. Soong, J. Kiell, F. D. Lakeman, R. J. Whitley, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2001. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108:223-229.
49. Kimberlin, D. W., and C. G. Prober. 2003. Antiviral agents, p. 1527-1547. In S. S. Long, L. K. Pickering, and C. G. Prober (ed.), Principles and practice of pediatric infectious diseases, 2nd ed. Churchill Livingstone, Philadelphia, Pa.
50. Kimura, H., M. Futamura, H. Kito, T. Ando, M. Goto, K. Kuzushima, M. Shibata, and T. Morishima. 1991. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 164:289-293.
51. Kinghorn, G. R. 1998. Type-specific serological testing for herpes simplex infection. Int. J. STD AIDS 9:497-500.
52. Kohl, S., M. S. West, C. G. Prober, W. M. Sullender, L. S. Loo, and A. M. Arvin. 1989. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J. Infect. Dis. 160:770-776.
53. Kulhanjian, J. A., V. Soroush, D. S. Au, R. N. Bronzan, L. L. Yasukawa, L. E. Weylman, A. M. Arvin, and C. G. Prober. 1992. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N. Engl. J. Med. 326:916-920.
54. Lafferty, W. E., L. Downey, C. Celum, and A. Wald. 2000. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 181:1454-1457.
55. Leach, C. T., R. L. Ashley, J. Baillargeon, and H. B. Jenson. 2002. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin. Diagn. Lab. Immunol. 9:1124-1125.
56. Lee, F. K., R. M. Coleman, L. Pereira, P. D. Bailey, M. Tatsuno, and A. J. Nahmias. 1985. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J. Clin. Microbiol. 22:641-644.
57. Lowhagen, G. B., P. Tunback, K. Andersson, T. Bergstrom, and G. Johannisson. 2000. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex. Transm. Infect. 76:179-182.
58. Malm, G., and M. Forsgren. 1999. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch. Dis. Child. Fetal Neonatal Ed. 81:F24-F29.
59. Markert, J. M., G. Y. Gillespie, R. R. Weichselbaum, B. Roizman, and R. J. Whitley. 2000. Genetically engineered HSV in the treatment of glioma: a review. Rev. Med. Virol. 10:17-30.
60. Markert, J. M., M. D. Medlock, S. D. Rabkín, G. Y. Gillespie, T. Todo, W. D. Hunter, C. A. Palmer, F. Feigenbaum, C. Tornatore, F. Tufaro, and R. L. Martuza. 2000. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase 1 trial. Gene Ther. 7:867-874.
61. Monif, G. R., K. R. Kellner, and W. H. Donnelly, Jr. 1985. Congenital herpes simplex type II infection. Am. J. Obstet. Gynecol. 152:1000-1002.
62. Nahmias, A. J., W. E. Josey, Z. M. Naib, M. G. Freeman, R. J. Fernandez, and J. H. Wheeler. 1971. Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 110:825-837.
63. Nahmias, A. J., H. L. Keyserling, and G. M. Kerrick. 1983. Herpes simplex, p. 636-678. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infants, 2nd ed. The W. B. Saunders Co., Philadelphia, Pa.
64. Nahmias, A. J., F. K. Lee, and S. Beckman-Nahmias. 1990. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. Suppl. 69:19-36.
65. Nilsen, A., and H. Myrmel. 2000. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet. Gynecol. Scand. 79:693-696.
66. Parker, J. D., and J. E. Banatvala. 1967. Herpes genitalis; clinical and virological studies. Br. J. Vener. Dis. 43:212-216.
67. Parvey, L. S., and L. T. Ch'ien. 1980. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes. Pediatrics 65:1150-1153.
68. Prince, H. E., C. E. Ernst, and W. R. Hogrefe. 2000. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J. Clin. Lab. Anal. 14:13-16.
69. Prober, C. G., P. A. Hensleigh, F. D. Boucher, L. L. Yasukawa, D. S. Au, and A. M. Arvin. 1988. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N. Engl. J. Med. 318:887-891.
70. Prober, C. G., W. M. Sullender, L. L. Yasukawa, D. S. Au, A. S. Yeager, and A. M. Arvin. 1987. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N. Engl. J. Med. 316:240-244.
71. Randolph, A. G., R. M. Hartshorn, and A. E. Washington. 1996. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis. Obstet. Gynecol. 88:603-610.
72. Randolph, A. G., A. E. Washington, and C. G. Prober. 1993. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA 270:77-82.
73. Reeves, W. C., L. Corey, H. G. Adams, L. A. Vontver, and K. K. Holmes. 1981. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N. Engl. J. Med. 305:315-319.
74. Reiff-Eldridge, R., C. R. Heffner, S. A. Ephross, P. S. Tennis, A. D. White, and E. B. Andrews. 2000. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am. J. Obstet. Gynecol. 182:159-163.
75. Ross, J. D., I. W. Smith, and R. A. Elton. 1993. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin. Med. 69:381-383.
76. Rowley, A. H., R. J. Whitley, F. D. Lakeman, and S. M. Wolinsky. 1990. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 335:440-441.
77. Schlesinger, Y., and G. A. Storch. 1994. Herpes simplex meningitis in infancy. Pediatr. Infect. Dis. J. 13:141-144.
78. Scott, L. L., L. M. Hollier, D. McIntire, P. J. Sanchez, G. L. Jackson, and G. D. Wendel, Jr. 2002. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect. Dis. Obstet. Gynecol. 10:71-77.
79. Scott, L. L., P. J. Sanchez, G. L. Jackson, F. Zeray, and G. D. Wendel, Jr. 1996. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet. Gynecol. 87:69-73.
80. Stanberry, L. R., S. L. Spruance, A. L. Cunningham, D. I. Bernstein, A. Mindel, S. Sacks, S. Tyring, F. Y. Aoki, M. Slaoui, M. Denis, P. Vandepapeliere, G. Dubin, and The GlaxoSmithKline Herpes Vaccine Efficacy Study Group. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347:1652-1661.
81. Stevens, D. A., G. W. Jordan, T. F. Waddell, and T. C. Merigan. 1973. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N. Engl. J. Med. 289:873-878.
82. Stevens, J. G., and M. L. Cook. 1971. Latent herpes simplex virus in spinal ganglia of mice. Science 173:843-845.
83. Stray-Pedersen, B. 1990. Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet 336:756.
84. Sullender, W. M., J. L. Miller, L. L. Yasukawa, J. S. Bradley, S. B. Black, A. S. Yeager, and A. M. Arvin. 1987. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 155:28-37.
85. Sullivan-Bolyai, J., H. F. Hull, C. Wilson, and L. Corey. 1983. Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates. JAMA 250:3059-3062.
86. Sullivan-Bolyai, J. Z., H. F. Hull, C. Wilson, A. L. Smith, and L. Corey. 1986. Presentation of neonatal herpes simplex virus infections: implications for a change in therapeutic strategy. Pediatr. Infect. Dis. 5:309-314.
87. Thompson, C. 2000. Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int. J. STD AIDS 11:501-502.
88. Troendle-Atkins, J., G. J. Demmler, and G. J. Buffone. 1993. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J. Pediatr. 123:376-380.
89. Vontver, L. A., D. E. Hickok, Z. Brown, L. Reid, and L. Corey. 1982. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am. J. Obstet. Gynecol. 143:75-84.
90. Wald, A., L. Corey, R. Cone, A. Hobson, G. Davis, and J. Zeh. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Investig. 99:1092-1097.
91. Wald, A., A. G. Langenberg, K. Link, A. E. Izu, B. Ashley, T. Warren, S. Tyring, J. M. Douglas, Jr., and L. Corey. 2001. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 285:3100-3106.
92. Whitley, R., A. Arvin, C. Prober, S. Burchett, L. Corey, D. Powell, S. Plotkin, S. Starr, C. Alford, J. Connor, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1991. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N. Engl. J. Med. 324:444-449.
93. Whitley, R., A. Arvin, C. Proher, L. Corey, S. Burchett, S. Plotkin, S. Starr, R. Jacobs, D. Powell, A. Nahmias, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1991. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N. Engl. J. Med. 324:450-454.
94. Whitley, R. J. 1990. Herpes simplex virus infections, p. 282-305. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infants, 3rd ed. The W. B. Saunders Co., Philadelphia, Pa.
95. Whitley, R. J. 1996. Herpes simplex viruses, p. 2297-2342. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
96. Whitley, R. J., L. T. Ch'ien, R. Dolin, G. J. Galasso, and C. A. Alford, Jr. 1976. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N. Engl. J. Med. 294:1193-1199.
97. Whitley, R. J., L. Corey, A. Arvin, F. D. Lakeman, C. V. Sumaya, P. F. Wright, L. M. Dunkle, R. W. Steele, S. J. Soong, and A. J. Nahmias. 1988. Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 158:109-116.
98. Whitley, R. J., A. J. Nahmias, S. J. Soong, G. G. Galasso, C. L. Fleming, and C. A. Alford. 1980. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66:495-501.
99. Whitley, R. J., A. J. Nahmias, A. M. Visintine, C. L. Fleming, and C. A. Alford. 1980. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 66:489-494.
100. Whitley, R. J., S. J. Soong, R. Dolin, R. Betts, C. Linnemann, Jr., and C. A. Alford, Jr. 1982. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N. Engl. J. Med. 307:971-975.
101. Whitley, R. J., S. J. Soong, R. Dolin, G. J. Galasso, L. T. Ch'ien, C. A. Alford, and The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 1977. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. N. Engl. J. Med. 297:289-294.
102. Whitley, R. J., A. Yeager, P. Kartus, Y. Bryson, J. D. Connor, C. A. Alford, A. Nahmias, and S. J. Soong. 1983. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics 72:778-785.
103. Wutzler, P., H. W. Doerr, I. Farber, U. Eichhorn, B. Helbig, A. Sauerhrei, A. Brandstadt, and H. F. Rabenau. 2000. Seroprevalence of herpes simplcx virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J. Med. Virol. 61:201-207.
104. Yeager, A. S., and A. M. Arvin. 1984. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 73:188-193.
105. Yeager, A. S., A. M. Arvin, L. J. Urbani, and J. A. Kemp III. 1980. Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect. Immun. 29:532-538.